Germline Determinants of Toxicity and Efficacy in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 Autologous CAR T-Cell Therapy

被引：0

作者：

Strati, Paolo ^{[1
]}

Brandt, Amanda ^{[2
]}

Henderson, Jared ^{[3
]}

Westin, Jason ^{[1
]}

Nastoupil, Loretta J. ^{[2
]}

Al Zaki, Ajlan ^{[4
]}

Jallouk, Andrew P. ^{[5
]}

Adkins, Sherry

Shpall, Elizabeth J. ^{[6
]}

Kebriaei, Partow ^{[6
]}

Ramdial, Jeremy ^{[6
]}

Saini, Neeraj Y. ^{[6
]}

Ahmed, Sairah ^{[7
]}

Flowers, Christopher R. ^{[1
]}

Neelapu, Sattva S. ^{[1
]}

Hildebrandt, Michelle ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Lymphoma Myeloma, Houston, TX 77030 USA

[5] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma & Stem Cell Transplantat, Houston, TX 77030 USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180744

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Deng, Qing
Han, Guangchun
Puebla-Osorio, Nahum
Ma, N. Chun John
Chasen, Paolo Strati Beth
Dai, Enyu
Dang, Minghao
Jain, Neeraj
Yang, Haopeng
Wang, Yuanxin
Zhang, Shaojun
Wang, Ruiping
Chen, Runzhe
Showell, Jordan
Ghosh, Sreejoyee
Patchva, Sridevi
Zhang, Qi
Sun, Ryan
Hagemeister, Frederick
Fayad, Luis
Samaniego, Felipe
Lee, Hans C.
Nastoupil, Loretta J.
Fowler, Nathan
Davis, R. Eric
Westin, Jason
Neelapu, Sattva S.
Wang, Linghua
Green, Michael R.
NATURE MEDICINE, 2020, 26 (12) : 1878 - 1887
[22] CAR T-Cell Therapy in Large B-Cell Lymphoma
Quintas-Cardama, Alfonso
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
[23] Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma
Abramson, Jeremy S.
Irwin, Kelly E.
Frigault, Matthew J.
Dietrich, Jorg
McGree, Brianne
Jordan, Justin T.
Yee, Andrew J.
Chen, Yi-Bin
Raje, Noopur S.
Barnes, Jeffrey A.
Davis, Benjamin
CANCER, 2019, 125 (21) : 3692 - 3698
[24] Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
Hill, Brian T.
Roth, Caroline J.
Kositsky, Rachel
Dave, Tushar
Love, Cassandra
McKinney, Matthew
Galal, Ahmed
Neff, Jadee L.
Mian, Agrima
Kendall, Ellen
Ondrejka, Sarah L.
Chiaramonte, Matthew
Bhagat, Govind
Ofori, Kenneth
Reshef, Ran
Kovach, Alexandra E.
Sethi, Tarsheen
Mason, Emily F.
Bhaskar, Shakthi
Oluwole, Olalekan O.
Pallas, Christopher
Ghosh, Nilanjan
Ferdman, Robert
Chen, George L.
Hernandez-Ilizaliturri, Francisco J.
Zurko, Joanna C.
Cunningham, Ashley
Shah, Nirav N.
Hu, Boyu
Stephens, Deborah M.
Ghosh, Monalisa
Bailey, Neil
Patel, Krish
Pagel, John M.
Kannan, Kavya Kannamma
Hsi, Eric D.
Vaidya, Rakhee
Ip, Andrew
Goy, Andre H.
Kambhampati, Swetha
Ohgami, Robert S.
Andreadis, Charalambos
Thacker, Elizabeth
Rozzi, Chrissie
Parker, Clay
Happ, Lanie
Dave, Sandeep S.
BLOOD, 2021, 138
[25] Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Crombie, Jennifer L.
Jacobson, Caron A.
Redd, Robert
Shouse, Geoffrey
Herrera, Alex F.
Chow, Victor A.
Gauthier, Jordan
Mullane, Erin
Cahill, Kirk
Kline, Justin
Romancik, Jason
Cohen, Jonathon B.
Saucier, Anna
Houot, Roch
Armand, Philippe
Hess, Brian
REVISTA CHILENA DE LITERATURA, 2023, (108): : 3433 - 3437
[26] Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Melody, Megan
Epperla, Narendranath
Shouse, Geoffrey
Romancik, Jason
Allen, Pamela
Moyo, Tamara K.
Kenkre, Vaishalee
Ollila, Thomas
Fitzgerald, Lindsey
Hess, Brian
David, Kevin
Herr, Megan M.
Odetola, Oluwatobi
Lin, Adam
Moreira, Jonathan
Ma, Shuo
Winter, Jane N.
Roy, Ishan
Stephens, Deborah
Danilov, Alexey
Shah, Nirav N.
Barta, Stefan K.
Cortese, Matthew
Cohen, Jonathon B.
Gordon, Leo I.
Karmali, Reem
BLOOD ADVANCES, 2024, 8 (10) : 2327 - 2331
[27] Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
Cordeiro, Ana Costa
Durisek, George
Batista, Marjorie Vieira
Schmidt, Jayr
de Lima, Marcos
Bezerra, Evandro
FRONTIERS IN ONCOLOGY, 2024, 14
[28] Effect of Delayed Cell Infusion in Patients with Large B-Cell Lymphoma Treated with CAR T-Cell Therapy
Jallouk, Andrew
Feng, Lei
Noorani, Mansoor
Das, Kaberi
Steiner, Raphael E.
Nastoupil, Loretta J.
Hawkins, Misha
Nair, Ranjit
Westin, Jason
Fayad, Luis
Chihara, Dai
Castillo, Luis Enrique Malpica
Iyer, Swaminathan P.
Ahmed, Sairah
Shpall, Elizabeth J.
Kebriaei, Partow
Neelapu, Sattva S.
Strati, Paolo
BLOOD, 2022, 140 : 10424 - 10426
[29] Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
Ursu, Renata
Maillet, Didier
Belin, Catherine
Moroni, Christine
Cuzzubbo, Stefania
Vernier, Victoria
Sirven-Villaros, Lila
Carreau, Christophe
Di Blasi, Roberta
Thieblemont, Catherine
Carpentier, Antoine F.
NEUROLOGY, 2022, 99 (12) : 511 - 515
[30] Transverse myelitis after anti-CD19 directed CAR T cell therapy for relapsed large B cell lymphoma
Sheikh, Semira
Mokhtari, Sepideh
Silverman, Jeffrey A.
Reid, Kayla
Faramand, Rawan
Davila, Marco L.
Franke, Norman
Locke, Frederick L.
Jain, Michael D.
Wong, Daniel
Kuruvilla, John G.
EJHAEM, 2022, 3 (01): : 223 - 227

← 1 2 3 4 5 →